PMC Links for Books (Select 4857082) - PMC

Select item 54974921.

Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?

Adrian M. Di Bisceglie, Anna S. Lok, Paul Martin, Norah Terrault, Robert P. Perrillo, Jay H. Hoofnagle

Hepatology. Author manuscript; available in PMC 2017 Jul 5.

Published in final edited form as: Hepatology. 2015 Feb; 61(2): 703–711. doi: 10.1002/hep.27609

PMCID:: PMC5497492

Abstract Article PDF–430K

Select item 45540522.

Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With Immunosuppressants: A French Retrospective Multicenter Study

Hélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, Sophie Fournier, Florence Abravanel, Alain Cantagrel, Emmanuel Chatelus, Pascal Claudepierre, Christophe Hudry, Jacques Izopet, Sylvie Fabre, Guillaume Lefevre, Laurent Marguerie, Antoine Martin, Laurent Messer, Anna Molto, Béatrice Pallot-Prades, Yves-Marie Pers, Anne-Marie Roque-Afonso, Christian Roux, Christelle Sordet, Martin Soubrier, Claire Veissier, Daniel Wendling, Jean-Marie Péron, Jean Sibilia

Medicine (Baltimore) 2015 Apr; 94(14): e675. Published online 2015 Apr 10. doi: 10.1097/MD.0000000000000675

PMCID:: PMC4554052

Abstract Article PDF–129K

Select item 44462353.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 43459084.

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jürgen Braun, Arthur Kavanaugh

Ann Rheum Dis. 2015 Mar; 74(3): 538–546. Published online 2013 Dec 16. doi: 10.1136/annrheumdis-2013-204195

PMCID:: PMC4345908

Abstract Article PDF–371K

Select item 41124445.

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

Bernard Combe, Bhaskar Dasgupta, Ingrid Louw, Sarvajeet Pal, Jürgen Wollenhaupt, Cristiano A F Zerbini, Andre D Beaulieu, Hendrik Schulze-Koops, Patrick Durez, Ruji Yao, Nathan Vastesaeger, Haoling H Weng

Ann Rheum Dis. 2014 Aug; 73(8): 1477–1486. Published online 2013 Jun 5. doi: 10.1136/annrheumdis-2013-203229

PMCID:: PMC4112444

Abstract Article PDF–1.8M

Select item 38128646.

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study

Arthur Kavanaugh, Iain B McInnes, Philip J Mease, Gerald G Krueger, Dafna D Gladman, Désirée van der Heijde, Surekha Mudivarthy, Weichun Xu, Michael Mack, Zhenhua Xu, Anna Beutler

Ann Rheum Dis. 2013 Nov; 72(11): 1777–1785. Published online 2012 Nov 17. doi: 10.1136/annrheumdis-2012-202035

PMCID:: PMC3812864

Abstract Article PDF–1.3M

Select item 34396507.

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Josef S Smolen, Jonathan Kay, Robert B M Landewé, Eric L Matteson, Norman Gaylis, Jurgen Wollenhaupt, Frederick T Murphy, Yiying Zhou, Elizabeth C Hsia, Mittie K Doyle

Ann Rheum Dis. 2012 Oct; 71(10): 1671–1679. doi: 10.1136/annrheumdis-2011-200956

PMCID:: PMC3439650

Abstract Article PDF–421K

Select item 33292308.

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study

Jürgen Braun, Atul Deodhar, Robert D Inman, Désirée van der Heijde, Michael Mack, Stephen Xu, Benjamin Hsu

Ann Rheum Dis. 2012 May 1; 71(5): 661–667. Published online 2011 Oct 19. doi: 10.1136/ard.2011.154799

PMCID:: PMC3329230

Abstract Article PDF–310K

Select item 32602649.

Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis

Kalle J. Aaltonen, Liisa M. Virkki, Antti Malmivaara, Yrjö T. Konttinen, Dan C. Nordström, Marja Blom

PLoS One. 2012; 7(1): e30275. Published online 2012 Jan 17. doi: 10.1371/journal.pone.0030275

PMCID:: PMC3260264

Abstract Article PDF–703K

Select item 267454910.

Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

E C Keystone, M C Genovese, L Klareskog, E C Hsia, S T Hall, P C Miranda, J Pazdur, S-C Bae, W Palmer, J Zrubek, M Wiekowski, S Visvanathan, Z Wu, M U Rahman

Ann Rheum Dis. 2009 Jun; 68(6): 789–796. Published online 2008 Dec 9. doi: 10.1136/ard.2008.099010

Correction in:: Ann Rheum Dis. 2011 Jan 1; 70(1): 238.

PMCID:: PMC2674549

Abstract Article PDF–380K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 10

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity